Isoxsuprine%25252525252525252525252525252525252525252520hydrochloride

# Isoxsuprine hydrochloride ## Overview Isoxsuprine hydrochloride is a vasodilator with $\beta$-adrenergic agonist activity. It is thought to cause smooth muscle relaxation, particularly in vascular and uterine muscles. ## Primary Indications * Treatment of peripheral vascular disease (PVD) and intermittent claudication. * To improve cerebral blood flow in cerebrovascular insufficiency. * To prevent premature labor (tocolytic agent) - *Note: Use as a tocolytic is generally considered off-label and less common due to safety concerns and availability of more effective agents.* ## Adult Dosing * **Peripheral Vascular Disease/Cerebrovascular Insufficiency:** Typically 10 mg to 20 mg orally four times daily. Doses may be increased to 40 mg four times daily if needed. * **Tocolysis (Off-label):** Dosing varies significantly. One common regimen involves an initial intravenous dose followed by oral maintenance doses, often starting at 10 mg every 4-6 hours. *Specific intravenous dosing and duration are highly dependent on institutional protocols and physician judgment.* ## Pediatric Dosing * No established pediatric dosing. Safety and efficacy have not been determined in pediatric populations. ## Dose Adjustments * No specific dose adjustments are typically recommended for renal or hepatic impairment. However, caution is advised, and close monitoring for adverse effects is warranted in patients with these conditions. ## Contraindications * Hypersensitivity to isoxsuprine hydrochloride. * Use in patients with congenital heart disease. * Use in patients who have had a recent myocardial infarction. * Use in patients with cardiac arrhythmias. * Use in patients with hypotension. ## Adverse Effects * **Common:** Flushing, nausea, vomiting, stomach upset, dizziness, weakness, headache, rash. * **Cardiovascular:** Hypotension, tachycardia, palpitations, arrhythmias (especially with high doses or intravenous administration). * **Other:** Drowsiness, nervousness. ## Key Drug Interactions * **Antihypertensives:** Isoxsuprine may potentiate the hypotensive effects of antihypertensive medications. * **Other Vasodilators:** Additive hypotensive effects. * **Sympathomimetics:** Potential for additive cardiovascular effects (tachycardia, hypertension). ## Monitoring * Blood pressure and heart rate, particularly at initiation of therapy or dose changes. * Signs and symptoms of peripheral vascular disease or cerebrovascular insufficiency. * For tocolysis: Maternal and fetal well-being, including uterine contractions, fetal heart rate, and signs of maternal adverse effects. ## Clinical Pearls * Isoxsuprine is generally not considered a first-line agent for PVD due to limited evidence of significant clinical benefit in many studies. * Oral administration is preferred. Intravenous use is typically reserved for specific situations, such as tocolysis, and requires careful monitoring. * Patients should be advised to report any adverse effects promptly, especially dizziness, palpitations, or hypotension. *** *Disclaimer: This information is intended for educational purposes only and does not constitute medical advice. Always consult the most current prescribing information, drug monographs, or a qualified healthcare professional for complete and up-to-date drug information, including specific dosing, indications, contraindications, warnings, precautions, adverse reactions, and drug interactions. Treatment decisions should be based on individual patient needs and clinical judgment.*